Trial Profile
Treatment of Dysglycemia Using Sitagliptin in Adolescents With Cystic Fibrosis
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary)
- Indications Glucose intolerance
- Focus Biomarker; Therapeutic Use
- 10 Jun 2016 Status changed from recruiting to completed.
- 10 Dec 2012 New trial record